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Myocardial Viability: 
Contractile Reserve or Cell 
Membrane Integrity?* 
VASKEN DILSIZIAN, MD, FACC 
Bethesda, Maryland 
The goal of myocardial viability assessment is to differentiate, 
prospectively, patients with potentially reversible from irre- 
versible left ventricular dysfunction. Ideally, such information 
would be used to guide therapeutic decisions for revascular- 
ization and risk stratification. 
Contrary to conventional wisdom, it is now well established 
that in patients with coronary artery disease, impaired left 
ventricular function at rest is not necessarily an irreversible 
process. Postischemic dysfunction (stunned myocardium) and 
chronic hypoperfusion (hibernating myocardium) are two 
pathophysiologic states in which viable myocardium will dem- 
onstrate reduced contractility and will be difficult to differen- 
tiate from scarred or necrotic myocardium (1,2). Because the 
relation between myocardial peffusion and left ventricular 
function differs among patients with stunned and hibernating 
myocardium, this may have significant implications regarding 
the technique used to assess myocardial viability. 
The evaluation of myocardial ischemia and viability by 
radionuclide techniques, uch as thallium scintigraphy, are 
firmly integrated into the management strategy of patients with 
known or suspected coronary artery disease. Radionuclide 
methods allow the assessment of regional peffusion, cell 
membrane integrity and metabolism, which have inherent 
advantages over techniques that assess regional function alone. 
Although the diagnostic utility of thallium scintigraphy is well 
established, measurement of contractile reserve with low dose 
dobutamine echocardiography has gained considerable inter- 
est for differentiating viable from nonviable myocardium in
recent years. By evaluating regional left ventricular wall mo- 
tion and systolic wall thickening under baseline conditions and 
during low dose dobutamine infusion, functional imaging with 
echocardiography may offer a simple, cost-effective alternative 
to radionuclide imaging for the assessment of myocardial 
viability. However, both methods are technically demanding 
and require highly skilled technicians and specialized equip- 
ment to achieve xcellent results. 
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Assessment of myocardial cell membrane integrity by thal- 
lium scintigraphy. Because the uptake of thallium by myocar- 
dial cells is dependent on both regional perfusion and cell 
membrane integrity, thallium scintigraphy has occupied a 
rather unique place in cardiac diagnostic imaging for both 
detecting coronary artery narrowing and distinguishing viable 
from scarred myocardium. Like potassium, thallium is trans- 
ported across the myocyte sarcolemmal membrane by the 
Na+/K+-ATPase transport system. Experimental studies with 
thallium have demonstrated that the cellular extraction of 
thallium across the cell membrane is unaffected by hypoxia 
unless irreversible injury is present. Similarly, pathophysiologic 
conditions of chronic hypoperfusion (hibernating myocar- 
dium) and postischemic dysfunction (stunned myocardium), in 
which regional contractile function is impaired in the presence 
of myocardial viability, do not adversely alter extraction of 
thallium. Thus, intracellular uptake of thallium across the 
sarcolemmal membrane is maintained for as long as sufficient 
blood flow is present to deliver thallium to the myocardial cell 
and to maintain myocyte viability. Thallium does not actively 
concentrate in regions of infarcted or scarred myocardium. 
Although standard stress/3- to 4-h redistribution thallium 
scintigraphy may underestimate the presence of ischemic but 
viable myocardium in many patients with coronary artery 
disease, reinjection of thallium at rest after stress/3- to 4-h 
redistribution imaging substantially improves the assessment 
of myocardial ischemia nd viability (3,4). That myocardial 
regions identified by thallium uptake after thallium reinjection 
represent viable myocardium is supported by improved re- 
gional function after revascularization (3) and preserved met- 
abolic activity by fluorodcoxyglucose (FDG) positron emission 
tomography (PET) (5). In addition, a significant inverse correla- 
tion between the magnitude of thallium activity after einjection 
and the regional volume fraction of interstitial fibrosis has been 
demonstrated in comparative clinicopathologic studies (6). 
Assessment of contractile reserve by dobutamine chocar- 
diography. Echocardiography is areadily available technology 
that allows the visualization of all cardiac structures and 
regional myocardial contraction. Positive inotropic effects of 
dobutamine (a synthetic atecholamine) are mediated pre- 
dominantly through betal-adrenergic receptor activation. The 
identification of viable myocardium with dobutamine imaging 
is based on the principle that whereas regional contractile 
function may be abnormal at rest, improved contractility with 
inotropic stimulation may differentiate viable (positive con- 
tractile reserve) from nonviable, scarred myocardium (negative 
contractile reserve). The utility of contractile reserve in pre- 
dicting recovery of left ventricular function after evasculariza- 
tion and in assessing prognosis has been shown after postex- 
trasystolic potentiation and epinephrine administration during 
left ventriculography. Although these studies with contrast or 
radionuclide ventriculography didnot gain widespread clinical 
enthusiasm when they were first published in the 1970s, studies 
with dobutamine infusion during echocardiography have gath- 
ered considerable interest in the 1990s. 
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Contractile reserve in asynergic myocardium. The utility of 
dobutamine chocardiography to predict recovery of function 
after revascularization was first described in patients with an 
acute myocardial infarction (7). Prolonged but reversible post- 
ischemic dysfunction despite restoration of coronary blood 
flow (stunned myocardium) may be prevalent in such patients. 
Data from these studies have indicated that dobutamine- 
responsive improvement in left ventricular wall motion is 
accurate in predicting functional recovery after infarction, even 
in patients who do not undergo revascularization. It was 
concluded, therefore, that contractile reserve may be un- 
masked by low dose catecholamine infusions in regions exhib- 
iting stunned myocardium. 
Whether low dose dobutamine chocardiography is simi- 
larly efficacious in the evaluation of the hibernating myocar- 
dium is uncertain because adequate animal models of chronic 
hypoperfusion are lacking to test this hypothesis. Although 
contractile reserve may be unmasked by low dose catechol- 
amine infusions in stunned myocardium, in which coronary 
flow has been restored, this may not pertain to regions 
rendered ysfunctional secondary to an adaptive, protective 
mechanism to maintain myocyte viability in the setting of 
chronic hypoperfusion. In patients with critically stenosed 
coronary arteries exhibiting reduction in coronary blood flow 
so severe at rest as to produce sustained regional contractile 
dysfunction, the administration of a positive inotropic agent 
(even at low doses) may merely increase myocardial demand, 
thereby producing myocardial ischemia nd persistent regional 
dysfunction. Furthermore, in the natural history of hiberna- 
tion, cellular de-differentiation and slippage of myofibrillar 
units may result in significantly reduced or absent responsive- 
ness to catecholamine stimulation (8). Despite this conceptual 
limitation, there are a number of published reports that 
suggest hat low dose dobutamine chocardiography may be 
useful in predicting functional recovery after revascularization 
in patients with chronic coronary artery disease and left 
ventricular dysfunction. In this issue of the Journal, Vanover- 
schelde t al. (9) report that low dose dobutamine echocardi- 
ography correctly predicted 75% of asynergic regions that 
improved after revascularization and 86% of regions that 
remained dysfunctional fter revascularization. The authors 
should be commended for addressing this timely topic. How- 
ever, similar to most of the previous tudies utilizing dobut- 
amine echocardiography, the current study also fails to provide 
an assessment of regional blood flow at rest. Because regional 
contractile dysfunction may be secondary to stunning (pre- 
served blood flow at rest) rather than hibernation (reduced 
blood flow at rest), assessment of regional perfusion is crucial 
to allow a comprehensive understanding of what clinical 
circumstances low dose dobutamine chocardiography can 
shed light on regarding reversibility or irreversibility of asyn- 
ergic regions. 
Comparative studies of dobutamine chocardiography with 
radionuclide techniques. Several studies have compared o- 
butamine chocardiography with radionuclide techniques for 
differentiating viable from nonviable myocardium in the same 
patients. The relation between dobutamine eehocardiography, 
stress-redistribution-reinjection thallium and FDG PET are 
reviewed. 
Relation to thallium scintigraphy. In patients with chronic 
coronary artery disease and left ventricular dysfunction studied 
at the National Institutes of Health (10), a significant relation 
was observed between thallium uptake (using the stress- 
redistribution-reinjection protocol) and contractile response 
to low dose dobutamine (using transesophageal chocardiog- 
raphy). Transesophageal r ther than transthoracic echocardi- 
ography was used because up to one-third of transthoracic 
echocardiographic images have been reported to be of subop- 
timal quality for adequate visualization of endocardial and 
epicardial contours of the left ventricle. Of 262 regions con- 
sidered viable by thallium, 167 (64%) showed improved con- 
tractile function with dobutamine. In contrast, only 6 (12%) of 
the 49 regions considered nonviable by thallium had a positive 
dobutamine response. Furthermore, among regions with rest 
wall motion abnormalities (in which viability assessment is a 
clinical concern), more regions were identified as viable by 
thallium than dobutamine chocardiography (84% vs. 56%, 
respectively, p < 0.001). These comparative data suggested 
that the discordance between the two techniques may reflect 
differences in the mechanisms by which they detect myocardial 
viability and that a positive inotropic response to dobutamine 
may require a greater number of viable, functional myocytes 
than is necessary for thallium uptake. This hypothesis is 
supported by the finding that a positive inotropic response to 
dobutamine was significantly related to the magnitude of 
thallium uptake; the proportion of regions with a positive 
contractile response to dobutamine rose with increasing mag- 
nitude of thallium uptake. In a subsequent study (11), when the 
dose of dobutarnine at which myocardial ischemia was first 
detected (ischemic threshold) was analyzed according to the 
extent of coronary artery disease, the dobutamine ischemic 
threshold was significantly lower in patients with two-vessel 
(14.4 _ 7.9 t~g/kg body weight per rain) and three-vessel 
coronary artery disease (9.1 +_ 7.9 p~g/kg per rain) than in 
patients with one-vessel coronary artery disease (25.4 +_ 
11.2/zg/kg per rain, p < 0.0001). The induction of ischemia t 
low doses of dobutamine (2.5 to 10 ~g/kg per rain) observed in 
a sizeable proportion of patients with two- and three-vessel 
coronary artery disease may explain why some regions identi- 
fied as viable by thallium may be underestimated as nonviable 
with low dose dobutamine echocardiography. 
Relation to PET. Studies comparing dobutamine chocar- 
diography with PET are limited at the present time. In patients 
with chronic coronary artery disease, 90% overall concordance 
between dobutamine transesophageal echocardiography and 
FDG PET was reported by Baer et al. (12). However, regional 
blood flow was not reported in the latter study. In subsequent 
studies, when both regional blood flow and metabolism were 
assessed by PET, dobutamine chocardiography significantly 
underestimated viability in hibernating but not in stunned 
myocardial regions. In patients with ischemic ardiomyopathy, 
Elsner et al. (13) compared low dose dobutamine chocardi- 
ography with PET perfusion and metabolism. Although 42 
(74%) of 57 of asynergic regions identified as stunned myocar- 
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dium by PET (normal ammonia nd normal or increased FDG 
uptake) improved with dobutamine, only 6 (16%) of 38 
asynergic regions identified as hibernating myocardium by 
PET (decreased ammonia with normal or increased FDG 
uptake) showed such improvement with low dose dobutamine 
(p < 0.001). In a similar study (14), 70% of regions assigned as 
nonviable by dobutamine echocardiography were determined 
to be viable by ammonia nd FDG PET. When functional 
recovery after revascularization was used as the reference 
standard (15), although the specificities of PET and dobut- 
amine echocardiography were similar (76% and 78%, respec- 
tively), PET showed greater sensitivity than dobutamine echo- 
cardiography (82% and 65%, respectively). These preliminary 
studies underscore the importance of assessing regional blood 
flow in asynergic regions when designing comparative studies 
between dobutamine echocardiography and nuclear techniques. 
Preoperative and postoperative studies. A number of studies 
have examined the ability of low dose dobutamine echocardi- 
ography to predict recovery of asynergic regions after revascu- 
larization. In patients with chronic oronary artery disease and 
left ventricular dysfunction, the sensitivity and specificity for 
predicting improvement in regional function after revascular- 
ization have ranged from 74% to 95%. More recently, it has 
been observed that certain myocardial regions may exhibit a 
"biphasic" response to graded dobutamine infusion (i.e., im- 
provement inwall motion at low dose but worsening at higher 
doses of dobutamine). In the study by Afridi et al. (16), the 
biphasic response had the most favorable predictive accuracy 
(72%) for recovery of rest function after revascularization but 
with a relatively poor sensitivity of only 60%. Additional 
studies in larger patient groups are needed to better define the 
various patterns of myocardial viability with dobutamine echo- 
cardiography. 
In the current study by Vanoverschelde et al. (9), 73 
patients with coronary artery disease and left ventricular 
regional asynergy underwent stress-redistribution-reinjection 
thallium single-photon emission computed tomography and 
low dose dobutamine echocardiography before revasculariza- 
tion. Regional thallium uptake was assessed quantitatively, and 
regional contraction by echocardiography was assessed semi- 
quantitatively (normal wall motion was defined as ~5-mm 
endocardial excursion and hypokinesia as <5-mm endocardial 
excursion). Recovery of regional asynergy and global left 
ventricular function was evaluated with echocardiography 
5.5 _+ 2.5 months after revascularization. As the authors 
appropriately point out in the introduction section, although 
most of the published reports have concentrated xclusively on 
predicting recovery of regional asynergy, it is global left 
ventricular function that is clinically relevant. The current data 
show that the overall accuracy of dobutamine echocardiogra- 
phy (84%) is similar to that achieved by thallium scintigraphy 
(73%) for predicting reversibility of global left ventricular 
dysfunction after revascularization (p = NS). When the data 
were assessed on a regional basis, although the sensitivities of 
dobutamine chocardiography and thallium were similar in 
predicting functional recovery after revascularization (75% 
and 77%, respectively), dobutamine echocardiography s owed 
greater specificity than thallium (86% and 56%, respectively). 
A potential limitation inherent in many comparative studies of 
this type, however, is that the test used to confirm viability 
(follow-up echocardiography) is the same as one of the tests 
used in the comparison (echocardiography and thallium). 
Application of the same imaging modality to both "test" and 
"confirm" myocardial viability before and after revasculariza- 
tion raises the potential for unintentional yet important bias 
against hallium scintigraphy, favoring more accurate anatomic 
alignment of corresponding echocardiographic regions before 
and after revascularization. This may explain, in part, the 
greater specificity achieved with dobutamine echocardiography 
than thallium when the data were analyzed on a regional basis 
but not on a global basis. Likewise, the inclusion of moderately 
reduced irreversible thallium defects as viable regions with the 
potential of recovery after revascularization may explain the 
lower specificity of thallium than dobutamine echocardiogra- 
play (9,15). When performing rest-redistribution studies, mod- 
erately reduced irreversible thallium defects represent viable 
myocardium with the potential of recovery after evasculariza- 
tion. However, the same concept may not apply when perform- 
ing stress studies. Most moderately irreversible thallium de- 
fects on stress studies represent an admixture of viable 
(nonischemic) and scarred myocardium and therefore may not 
improve after revascularization (17). Although regions with 
moderately reduced irreversible thallium defects indeed retain 
viable myocardium, the mere presence of viable myocardium 
does not necessarily indicate ischemic myocardium. 
The second limitation is that although follow-up echocar- 
diograms were obtained 5.5 _ 2.5 months after the revascu- 
larization procedure, follow-up thallium studies were not ac- 
quired. In the absence of postoperative coronary angiography 
to assess vessel patency, repeat hallium studies postopera- 
tively would have been useful in determining whether the 
revascularization procedure was successful (normal postoper- 
ative thallium uptake), incomplete (partial thallium reversibil- 
ity) or unsuccessful (irreversible thallium defect). This may be 
especially relevant because nhanced contractility induced by 
dobutamine in a region with an admixture of viable and scarred 
myocardium ay lead to false-positive interpretation (as in 
hypokinetic regions). In addition, tethering or recruitment of
abnormal regions due to adjacent hyperdynamic contraction 
may also lead to false-positive interpretation. 
Definition of myocardial viability: preserved regional con- 
traction or cellular metabolism? The observed iscrepancies 
between dobutamine echocardiography, thallium scintigraphy 
and metabolic activity with PET may reflect the underlying 
alterations incellular metabolism and function. Cellular mech- 
anisms responsible for a positive inotropic response to adren- 
ergic stimulation may require a higher degree of myocyte 
functional integrity than those responsible for thallium or FDG 
uptake. With this in mind, perhaps the most important ques- 
tion relates to the definition of myocardial viability itself. 
The definition of myocardial viability has been variable in 
the published reports. Viable myocardium ay represent 
normal, nonischemic myocardium or ischemic but reversibly 
dysfunctional myocardium. One definition of viable myocar- 
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dium has been the temporal improvement in contractile func- 
tion after specific therapeutic interventions, most commonly 
restoration of coronary artery blood flow, Coronary artery 
revascularization may restore blood flow and contraction in 
regions with stunned and hibernating myocardium. However, 
restoration of blood flow does not necessarily translate to 
improvement in contractile function in all regions. There are a 
number of local and extrinsic conditions that may influence 
regional myocardial function. Restoration of blood flow to 
viable myocardium, for example, may not result in significant 
improvement in regional function in the setting of admixture of 
scarred and viable myocardium or nontransmural infarction, 
where an epicardial rim of viable myocardiurn is tethered to an 
endocardial scar, but may result in the prevention of extensive 
ventricular remodeling in nontransmural infarct zones. There 
are a number of retrospective clinical data to support the 
hypothesis that a patent infarct-related artery improves clinical 
outcome independently of left ventricular function (18-21). A 
recent prospective study (22) of patients with acute myocardial 
infarction and moderately reduced left ventricular ejection 
fraction confirmed that after adjustment for differences in 
baseline characteristics and left ventricular function, the pa- 
tency of the infarct-related artery remained an independent 
predictor of all-cause and cardiovascular mortality. Although 
the potential mechanisms for the improved survival in patients 
with a patent infarct-related artery have not been fully eluci- 
dated, it has been suggested (23,24) that anterograde flow in 
the infarct-related artery may prevent geometric alterations in 
the left ventricular shape and promote lectrical stability in the 
peri-infarct zone and, thereby, prognosis. 
These auxiliary potential benefits of revascularization (i - 
dependent of regional contraction) raise additional, still unan- 
swered questions with regard to how and why we assess 
myocardial viability in patients with coronary artery disease. If 
success of revascularization is evaluated exclusively on the 
basis of recovery of global or regional left ventricular dysfunc- 
tion, or both, after revascularization, this may underestimate 
the potential benefits of revascularization a d thus the signif- 
icance of the delineation of viable myocardium. Even in the 
absence of changes in regional function, reperfusion of viable 
myocardium may have important effects on left ventricular 
remodeling, arrhythmic potential and long-term prognosis. In 
the future, large clinical trials will be needed to evaluate not 
only recovery of left ventricular function after revasculariza- 
tion, but also the impact of reperfusion on left ventricular 
cavity dilation, arrhythmias, recurrent ischemic events and 
long-term outcome. 
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